I. Mattisson

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE−/− mice

H. Scher, J. Nilsson, M. Wigren, 2016, Scientific Reports.

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.

A. Bengtsson, I. Gunnarsson, E. Svenungsson, 2018, Atherosclerosis.

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease

P. Almgren, O. Melander, M. Orho-Melander, 2017, EBioMedicine.

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.

A. Bengtsson, M. Lebens, J. Holmgren, 2021, Vascular pharmacology.

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice

J. Borén, J. Nilsson, Stacey Ruiz, 2021, Scientific Reports.

Regulation of Smooth Muscle Dystrophin and Synaptopodin 2 Expression by Actin Polymerization and Vascular Injury

P. Hellstrand, J. Wohlfahrt, P. Cidad, 2015, Arteriosclerosis, thrombosis, and vascular biology.

FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events

O. Melander, G. Engström, J. Nilsson, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes

I. Gonçalves, H. Björkbacka, J. Nilsson, 2016, Stroke.